Madiyalakan; Ragupathy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Madiyalakan; Ragupathy.The latest application filed is for "muc16 monoclonal antibody and uses thereof".

Company Profile

7.16.29

Madiyalakan; Ragupathy - Edmonton CA
Madiyalakan; Ragupathy - Alberta CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant Grant 11,351,255 - Nicodemus , et al. June 7, 2	2022-06-07
Methods of increasing delivery of anti-cancer agents to targets Grant 10,975,163 - Madiyalakan , et al. April 13, 2	2021-04-13
Muc16 Monoclonal Antibody And Uses Thereof App 20210101994 - Madiyalakan; Ragupathy ; et al.	2021-04-08
Method Of Indirect Immunization Of Human Ovarian Cancer Patients Through Selection Of Xenogeneic Immunoglobulin Fc Portions App 20200206347 - Madiyalakan; Ragupathy ; et al.	2020-07-02
Treatment Of Cancer With Therapeutic Monoclonal Antibody Specific For A Tumor Associated Antigen And An Immune Adjuvant App 20200101159 - NICODEMUS; CHRISTOPHER F. ; et al.	2020-04-02
Method Of Indirect Immunization Of Human Ovarian Cancer Patients Through Selection Of Xenogeneic Immunoglobulin Fc Portions App 20200093925 - Madiyalakan; Ragupathy ; et al.	2020-03-26
Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant Grant 10,537,636 - Nicodemus , et al. Ja	2020-01-21
Tumor Antigen Specific Antibodies And Tlr3 Stimulation To Enhance The Performance Of Checkpoint Interference Therapy Of Cancer App 20190322760 - Madiyalakan; Ragupathy ; et al.	2019-10-24
Tumor antigen specific antibodies and TLR3 stimulation to enhance the performance of checkpoint interference therapy of cancer Grant 10,392,444 - Madiyalakan , et al. A	2019-08-27
Treatment Of Cancer With Therapeutic Monoclonal Antibody Specific For A Tumor Associated Antigen And An Immune Adjuvant App 20180221477 - Nicodemus; Christopher F. ; et al.	2018-08-09
Treatment Of Cancer With Therapeutic Monoclonal Antibody Specific For A Tumor Associated Antigen And An Immune Adjuvant App 20180221476 - NICODEMUS; Christopher F. ; et al.	2018-08-09
Methods Of Increasing Delivery Of Anti-cancer Agents To Targets App 20180002441 - Madiyalakan; Ragupathy ; et al.	2018-01-04
Tumor Antigen Specific Antibodies And Tlr3 Stimulation To Enhance The Performance Of Checkpoint Interference Therapy Of Cancer App 20170226221 - Madiyalakan; Ragupathy ; et al.	2017-08-10
Polymeric nanoparticles for photosensitizers Grant 8,916,205 - Haddadi , et al. December 23, 2	2014-12-23
Polymeric Nanoparticles For Photosensitizers App 20140170229 - Haddadi; Azita ; et al.	2014-06-19
Method and device for photodynamic therapy Grant 8,454,991 - Woo , et al. June 4, 2	2013-06-04
Combination therapy for treating disease Grant 8,038,994 - Schultes , et al. October 18, 2	2011-10-18
Nanoparticles For Cancer Sonodynamic And Photodynamic Therapy App 20100262115 - MADIYALAKAN; Ragupathy ; et al.	2010-10-14
Reagents and methods for inducing an immune response to prostate specific antigen App 20090220493 - Leveugle; Beatrice ; et al.	2009-09-03
Reagents and methods for inducing an immune response to prostate specific antigen Grant 7,579,445 - Leveugle , et al. August 25, 2	2009-08-25
Method for diagnosing efficacy of xenotypic antibody therapy App 20090202560 - Madiyalakan; Ragupathy ; et al.	2009-08-13
Method And Device For Photodynamic Therapy App 20090204057 - Woo; Thomas ; et al.	2009-08-13
Combination therapy for treating disease App 20080311127 - Schultes; Birgit C. ; et al.	2008-12-18
Therapeutic Compositions that alter the immune response App 20080220012 - Madiyalakan; Ragupathy ; et al.	2008-09-11
Therapeutic compositions that alter the immune response App 20080206318 - Madiyalakan; Ragupathy ; et al.	2008-08-28
Method and composition for reconforming multi-epitopic antigens to intiate an immune response App 20080131443 - Madiyalakan; Ragupathy ; et al.	2008-06-05
Therapeutic compositions that produce an immune response Grant 7,361,346 - Madiyalakan , et al. April 22, 2	2008-04-22
Therapeutic binding agents against MUC-1 antigen and methods for their use App 20080019990 - Madiyalakan; Ragupathy	2008-01-24
Therapeutic compositions that alter the immune response Grant 7,318,921 - Madiyalakan , et al. January 15, 2	2008-01-15
Method and composition for reconforming multi-epitopic antigens to initiate an immune response App 20070036798 - Madiyalakan; Ragupathy ; et al.	2007-02-15
Therapeutic binding agents against MUC-1 antigen and methods for their use Grant 7,147,850 - Madiyalakan December 12, 2	2006-12-12
Method for diagnosing efficacy of xenotypic antibody therapy App 20060159688 - Madiyalakan; Ragupathy ; et al.	2006-07-20
Reagents and methods for inducing an immune response to prostate specific antigen App 20050202018 - Leveugle, Beatrice ; et al.	2005-09-15
Reagents and methods for inducing an immune response to prostate specific antigen Grant 6,881,405 - Leveugle , et al. April 19, 2	2005-04-19
Combination therapy for treating disease App 20050063976 - Schultes, Birgit C. ; et al.	2005-03-24
Therapeutic binding agents against MUC-1 antigen and methods for their use App 20050048059 - Madiyalakan, Ragupathy ; et al.	2005-03-03
Therapeutic binding agents against MUC-1 antigen and methods for their use Grant 6,716,966 - Madiyalakan April 6, 2	2004-04-06
Reagents and methods for inducing an immune response to prostate specific antigen App 20020136715 - LEVEUGLE, BEATRICE ; et al.	2002-09-26
Therapeutic binding agents against MUC-1 antigen and methods for their use App 20020132771 - Madiyalakan, Ragupathy	2002-09-19
Therapeutic Compositions That Alter The Immune Response App 20020048586 - MADIYALAKAN, RAGUPATHY ; et al.	2002-04-25
Method and composition for reconforming multi-epitopic antigens to initiate an immune response App 20010036457 - Madiyalakan, Ragupathy ; et al.	2001-11-01
Method and composition for reconforming multi-epitopic antigens to initiate an immune response Grant 6,241,985 - Madiyalakan , et al. June 5, 2	2001-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.